» Authors » Ayman Elgamal

Ayman Elgamal

Explore the profile of Ayman Elgamal including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 91
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mousa N, Salah M, Elbaz S, Elmetwalli A, Elhammady A, Abdelkader E, et al.
Gut Pathog . 2024 Apr; 16(1):18. PMID: 38561807
Background: The neutrophil percentage-to-albumin ratio (NPAR) is a novel measure of systemic inflammation and infection. Low albumin levels increase the risk of infection, while high neutrophil counts indicate the presence...
2.
Elbaz S, Mousa N, Elmetwalli A, Abdel-Razik A, Salah M, Elhammady A, et al.
BMC Infect Dis . 2024 Jan; 24(1):134. PMID: 38273234
Background: Cytokines play a crucial role in regulating the function of the immune system by controlling the production, differentiation, and activity of immune cells. Occult hepatitis C virus (OHCV) infection...
3.
Elabd N, Soliman S, Elhamouly M, Gohar S, Elgamal A, Alabassy M, et al.
Appl Clin Genet . 2022 Aug; 15:97-109. PMID: 35937710
Background: We aimed to evaluate the diagnostic roles of AFAP1-AS1 and ASB16-AS1 in colorectal cancer and highlight their roles in predicting colorectal cancer patients' prognosis. Methods: In this case-control study,...
4.
Abdel-Razik A, Mousa N, Shabana W, Refaey M, Elhelaly R, Elzehery R, et al.
Helicobacter . 2018 Sep; 23(6):e12537. PMID: 30246507
Background And Aim: The relationship between Helicobacter pylori (H. pylori) and nonalcoholic fatty liver disease (NAFLD) is a matter of debate. We achieved this prospective work to study whether H. ...
5.
Abdel-Razik A, Mousa N, Shabana W, Refaey M, Elzehery R, Elhelaly R, et al.
Eur J Gastroenterol Hepatol . 2018 Aug; 30(10):1237-1246. PMID: 30096092
Background/aims: The pathogenesis of nonalcoholic fatty liver disease (NAFLD) may include increased insulin resistance, upregulation of proinflammatory cytokines, lipopolysaccharide, and BMI. Rifaximin is a minimally absorbable antibiotic that might act...
6.
Mousa N, Abdel-Razik A, Farag R, Shabana W, Elgamal A, El-Wakeel N, et al.
Eur J Gastroenterol Hepatol . 2017 Jul; 29(9):1004-1009. PMID: 28749790
Background And Aim: There are millions of chronic hepatitis C (CHC) virus-infected patients who have been treated with a combination therapy (interferon and ribavirin) and have achieved a virological response...